Emtricitabine (FTC)
Emtricitabine (FTC) is a new nucleoside agent that has activity against both human immunodeficiency virus (HIV) and hepatitis B virus. It is a reverse transcriptase inhibitor. Intracellular half-life is 39 h.
| Trivial name | BW 1592 |
| Catalog Number | S1704 |
| Molecular Formula | C19H14F2N6O |
| CAS# | 143491-57-0 |
| Inchi | InChI=1S/C19H14F2N6O/c1-27-18(22-8-23-27)15-16(9-2-4-10(20)5-3-9)24-13-7-11(21)6-12-14(13)17(15)25-26-19(12)28/h2-8,15-16,24H,1H3,(H,26,28)/t15-,16-/m1/s1 |
| Inchi Key | HWGQMRYQVZSGDQ-HZPDHXFCSA-N |
| SMILES | CN1C(=NC=N1)C2C(NC3=CC(=CC4=C3C2=NNC4=O)F)C5=CC=C(C=C5)F |
| Size | 10mg |
| Supplier Page | http://www.selleckchem.com/products/Emtricitabine.html |
| Additional Information | https://file.selleck.cn/downloads/struct/Emtricitabine-Emtriva-chemical-structure-S1704.gif |
